VERSATOPE THERAPEUTICS, INC.

Immuno-Therapeutics Through a Customized Biotechnology Platform

LOWELL, United States · Founded 2018

Employees
11–50
Founded
2018
Business Model
B2G
Last Round
GrantJan 2024
Rounds
1

About

Versatope Therapeutics is a clinical-stage infectious disease company that uses synthetic biology to engineer recombinant nanovesicles derived from microbial membranes as a platform for targeted vaccine and immunotherapeutic delivery. The company's lead program, VT-105, is a universal influenza A vaccine candidate that has received IND allowance. Versatope's platform is also being applied to malaria vaccine development.

Summary

VERSATOPE THERAPEUTICS, INC. is a Biotech company based in LOWELL, United States, founded in 2018. Its most recent funding was a Grant round in Jan 2024. Investors include MassVentures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJan 2024

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

VERSATOPE THERAPEUTICS, INC. on Indexed.vc
<a href="https://indexed.vc/companies/versatope-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/versatope-therapeutics-inc" alt="VERSATOPE THERAPEUTICS, INC. on Indexed.vc" width="260" height="76" /></a>